Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatic Perfusion and Liver Health as Assessed by Dual Cholate Clearance Assay in Fontan-associated Liver Disease (FALD)

NCT07009132 is registered in ClinicalTrials.gov with HepQuant, LLC as lead sponsor.

NCT NCT07009132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07009132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatic Perfusion and Liver Health as Assessed by Dual Cholate Clearance Assay in Fontan-associated Liver Disease (FALD)
Lead sponsor
HepQuant, LLC
Phase
Observational
Overall status
Recruiting
Start date
August 4, 2025
Completion date
December 31, 2031
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fontan, right heart failure